Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK) (QUALANGIO)

Centre Hospitalier Universitaire de Besancon

Status: Completed

Conditions: Angioedema

Treatments: Other: Quality of life

Study type: Observational

Funder types: Other

Identifiers

NCT03240991

P/2016/302

Details and patient eligibility

About

This study aims to describe quality of life in hereditary or acquired non drug-related bradykinin-mediated angioedema patients, using validated questionnaires

Enrollment: 45 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinically documented angioedema due to C1 inhibitor deficiency, hereditary (type I et II) or acquired
• Clinically documented angioedema with normal C1 inhibitor activity (hereditary type III)

Exclusion criteria

• Acquired angioedema with normal C1 inhibitor activity (former "drug-induced")
• Minor subjects
• Vulnerable subjects (under guardianship/curatorship/tutorship)
• Pregnant women

Trial design

45 participants in 1 patient group

Quality of life questionnaires

Description:

Data will be collected retrospectively and prospectively.

Treatment:

Other: Quality of life